Appointment of Head of US Investment Banking Operations
Sydney, Sep 9, 2015 AEST (ABN Newswire) - iQ3Corp Ltd (
ASX:iQ3) is pleased to announce the appointment of Mr. David Batista to head up the investment banking operations of its U.S. subsidiary, iQ Capital LLC, based in New York.
David has over 20 years of diversified capital markets experience as an investment banker and trader. Importantly, he has demonstrable U.S./Australian cross-border experience in capital raising, strategic advisory and financial advisory.
He has a Bachelor of Science in Business Administration and a Certificate in International Marketing from C.W. Post College. He is also FINRA Series 7, 24, 55, 63, 79 and 99 registered.
iQ3Corp's CEO, Dr. George Syrmalis, says "iQ3Corp welcomes David to our global team. It will be a pleasure to work with David at this strategic point where insight meets execution; where life science research translates into tangible, life changing technologies."
David's core mandate is to create a model investment bank that will address the unique financial needs of the emerging global life science sector and, in particular, the needs of early stage biotechnology companies.
Through David's leadership of the investment banking entity, iQ Capital LLC, iQ3Corp seeks to lead the investment community, practitioners and observers in establishing the biotech industry as the most critical asset option within the alternative asset class.
David is building a best-in-class team of people that will enable our investment banking entity, iQ Capital LLC, to engage in:
Debt or Equity Offerings Through Public or Private Placement
> Pricing of securities in the debt and equity offerings
> Origination, which deals with equity capital markets and debt capital markets
> Underwriting
> Marketing
> Structuring
> Syndication
> Managing the allocation and stabilisation activities of offerings
Mergers, Acquisitions and Financial Restructuring
> Tender offers
> Selling assets
> Corporate reorganisation or divestitures
> Transactions involving business combinations, which might include rendering opinions solvency and fairness opinions
General Broker Dealer activities
David's unique experience in the U.S., European and Australian capital markets, together with his understanding of the cross-border investment dynamics across these regions, provide the foundations for iQ3Corp to expand its capital market distribution network into the U.S.
About iQ Capital:
Investing in the medicines of the future
iQ Capital is a dedicated life science investment bank, physically creating the bridge between investors and the biopharma industry.
About iQ3Corp Ltd
iQ3Corp Ltd (ASX:IQ3) is the world's first specialised life science corporate financial advisory and asset management firm.
iQ3Corp capitalises on its relationship with The iQ Group Global Companies and other industry participants such as academic institutions, financial market participants and other Life Science industry bodies, to provide a turnkey solution for capital raising from corporate inception to the capital markets.
iQ3 provides advice to life science companies on mergers and acquisitions, strategic matters, restructuring and capital structure, capital raising and corporate finance, as well as asset management services to corporations, partnerships, institutions, governments, and individuals.
| ||
|
